Definitive Contract FA865019C6065
Award Date 9/24/19
Potential Completion Date 9/27/23
Potential Value $3M
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Princeton, NJ, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This contract was awarded by the Department of the Army Medical Command to Cytosorbents Medical Inc., doing business as Cytosorbents, a for-profit small business manufacturer of medical devices and technologies. The $999,871.34 fixed-price level of effort contract is for Phase II of a Small Business Innovation Research (SBIR) project to develop blood purification technologies. Cytosorbents, as the prime contractor, is providing research and prototype development services to the Defense Health...
- This is a $1,499,987.16 Firm Fixed Price Definitive Contract awarded by the U.S. Army Medical Command (MEDCOM) to Cytosorbents Medical Inc., a small business manufacturer, under the Small Business Innovation Research (SBIR) program. The contract is for medical research and development to investigate a potassium adsorber for treating hyperkalemia resulting from traumatic injury and acute kidney injury in austere environments. This is a Phase II SBIR action with a completion date of February 20,...
- This is a $999,996.59 firm-fixed-price Phase II SBIR contract awarded by the Joint PEO Chemical and Biological Defense to Cytosorbents Medical Inc., a small business manufacturer of medical devices and technologies. The contract is for research and prototype development services related to Cytosorbents' blood purification technologies, including an extracorporeal cytokine adsorber, a potassium adsorber, and a blood group antibody adsorber. These technologies are intended to treat critical care...
- This is a $149,979 firm-fixed-price Definitive Contract awarded by the United States Army Medical Command (MEDCOM) to Cytosorbents Medical Inc., a small business manufacturer of medical devices and technologies. The contract was awarded under the Small Business Innovation Research (STTR) program for Phase I research, with the goal of developing an extracorporeal cytokine adsorber to treat septic shock. As a small business, this contract award was set aside for Cytosorbents as the prime...
- This federal contract award, with a ceiling value of $149,927.17, was issued by the U.S. Medical Command (MEDCOM) to Cytosorbents Medical Inc., a small business manufacturer of medical devices and technologies. The contract is for a SBIR Phase I research project under the Defense Health Program (DHP), with the goal of developing an extracorporeal cytokine adsorber to treat septic shock. As a small business set-aside, Cytosorbents is the prime contractor responsible for conducting the research to...
- Cytosorbents Medical Inc., doing business as Cytosorbents and classified as a small disadvantaged business, has been awarded a $74,918 firm fixed price purchase order by the Department of the Air Force Materiel Command Research Laboratory. The contract is set aside for total small business and involves research and development of a novel sorbent technology for the rapid treatment of acute joint injury and inflammation under the Small Business Innovation Research Program Phase I. Work will be...
- The Defense Health Agency awarded a $2.9 million firm fixed-price Phase III Small Business Technology Transfer Research (STTR) contract to Cytosorbents Medical Inc. on June 15, 2020, for the development of a highly efficient adsorber to remove anti-A and anti-B antibodies from blood and plasma for transfusion applications. The contract, designated as a total small business set-aside, is scheduled for completion by October 14, 2023, with performance taking place at the contractor's facility in...
- This $1.1 million firm fixed price contract was awarded by the Department of the Army Medical Command to Cytosorbents Medical Inc., doing business as Cytosorbents, to support research and development of an adsorber to remove anti-A and anti-B antibodies from plasma for transfusion under the Small Business Innovation Research (SBIR) Program Phase II solicitation. As a total small business set-aside, the contract aims to further the prime contractor's development of an effective adsorber that...
- The U.S. Army Medical Command awarded a $4.3M Phase III Small Business Innovation Research (SBIR) contract to Cytosorbents Medical Inc. on August 22, 2022, for research and development of a universal dried plasma product designed for battlefield and first responder use. The contract, which carries a firm fixed-price structure and is set aside for small business, focuses on integrating isoagglutinin reduction technology to enable universal blood transfusions in emergency and combat scenarios....
- The Air Force Research Laboratory awarded a $1.8M Small Business Technology Transfer Phase II contract to Perfusion Medical LLC on February 9, 2024, for research and development of optimal dosing and formulation of PM-208 (PEG-20K/8K) for Air Force field use. The contract, designated as a Total Small Business set-aside, is structured as a firm fixed-price purchase order with performance in Herndon, Virginia and an ultimate completion date of April 7, 2026. Perfusion Medical is a small...